FLUTICASONE/ SALMETEROL XINAFOATE INHALER (AirFluSal Forspiro®)

Clinical Indication

COPD and Asthma

Comments

Reviewed by LLR Respiratory Prescribing Group.

Date of classification

February 2017

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety